close

Clinical Trials

1 2 3 4 227
Number of results: 4521

PDF print is not allowed for data more than 300.Please search above for fewer data.

Date Product Disease Phase Company Therapeutic area
2019-01-29 M254 immune thrombocytopenic purpura 1-2 Momenta Pharmaceuticals (USA - MA) Autoimmune diseases - Rare diseases - Hematological diseases
2019-01-29 tanezumab osteoarthritis pain 3 Eli Lilly (USA - IN) Pfizer (USA - NY) Rheumatic diseases - Inflammatory diseases
2019-01-29 DPX-Survivac ovarian cancer 2 Immunovaccine Technologies (Canada) Cancer - Oncology
2019-01-25 MGD009 / MGD009 and MGA012 advanced solid tumors 1 Macrogenics (USA - MD) Cancer - Oncology
2019-01-25 BN-Brachyury; a heterologous prime/boost therapeutic cancer vaccine composed of MVA-BN-Brachyury (prime) and FPV-Brachyury (boost) advanced chordoma 2 Bavarian Nordic (Denmark) Cancer - Oncology - Rare diseases
2019-01-24 ABP 798 (biosimilar version of Mabthera®/Rituxan® - rituximab) non-Hodgkin lymphoma, rheumatoid arthritis 3 Amgen (USA - CA) Cancer - Oncology
2019-01-24 CTP-692 schizophrenia 1 Concert Pharmaceuticals (USA - M Mental diseases - CNS diseases
2019-01-24 CA-170 mesothelioma 1 Curis (USA - MA) Cancer - Oncology
2019-01-24 vaccine against the equine encephalitis virus equine encephalitis Bavarian Nordic (Denmark) Infectious diseases
2019-01-23 inolimomab (Leukotac®) acute steroid-resistant graft versus host disease (SR-aGvHD) 3 Elsalys Biotech (France) Transplantation
2019-01-22 genome variant data of 500 000 biobank participants Finnish biobanks and respective Universities, University Hospitals, the Institute of Health and Welfare (THL), the Finnish Red Cross Blood Service (Finland) Abbvie (USA - IL) AstraZeneca (UK)  Biogen (USA - MA) Celgene (USA - NJ) GSK (UK) Roche (Switzerland) Merck & Co (US - NJ)  Pfizer (USA - NY) Sanofi (France)
2019-01-21 EDIT-101 Leber Congenital Amaurosis 10 (LCA10) preclinical Editas Medicine (USA - MA) Rare diseases - Genetic diseases - Ophtalmological diseases
2019-01-21 high doses of GNbAC1 - temelimab multiple sclerosis 1 Geneuro (Switzerland) Neurodegenerative diseases
2019-01-08 DNL747 amyotrophic lateral sclerosis (ALS) 1b Denali Therapeutics (USA - CA) Sanofi (France) Rare diseases - Genetic diseases - Neurodegenerative diseases - Neurological diseases
2019-01-07 MRx0518 and pembrolizumab solid tumours (non small cell lung cancer, renal cell carcinoma, bladder cancer or melanoma) 1 4D Pharma (UK) Merck&Co (USA - NJ) Cancer - Oncology
2019-01-04 ARV-110 metastatic castration-resistant prostate cancer (mCRPC) 1 Arvinas (USA - CT) Cancer - Oncology
2019-01-04 Epicel® (cultured epidermal autografts) Vericel Corporation (formerly Aastrom Biosciences) (USA - MA)
2019-01-04 Firdapse® (amifampridine phosphate) MuSK antibody positive Myasthenia Gravis (MuSK-MG) 2b Catalyst Biosciences (USA - CA) Rare diseases - Neuromuscular diseases
2019-01-04 DTX401 glycogen storage disease type Ia (GSDIa) 1-2 Ultragenyx Pharmaceutical (USA - CA) Rare diseases - Genetic diseases - Metabolic diseases
2018-12-28 pacritinib myelofibrosis 2 CTI BioPharma - previously known as Cell Therapeutics (USA - WA) Cancer - Oncology